3 Small-Cap COVID Stocks With Huge Upside

08:00am, Thursday, 25'th Nov 2021
Three Fool.com contributors are bullish on Beyond Air, Ocugen, and Fulgent Genetics.
Fulgent's recent earnings report confirmed the strength of its core testing business.
Related Stocks: FLGT ,
These awesome stocks don't need COVID-19 to beat the market.
IFG Advisory LLC lifted its stake in shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) by 2.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,683 shares of the companys stock after acquiring an additional 150 shares during the quarter. IFG Advisory LLCs holdings []
Metropolitan Life Insurance Co NY raised its holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) by 141,875.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,679 shares of the companys stock after purchasing an additional 5,675 shares during the quarter. Metropolitan Life Insurance Co []
The key is by focusing on doctors.
Fullgent Genetics (FLGT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

What Investors Should Like About Fulgent Genetics'' Q3 Results

12:01pm, Friday, 19'th Nov 2021 The Motley Fool
The genetic testing company delivered a solid performance in Q3.

Best Momentum Stocks to Buy for November 19th

11:30am, Friday, 19'th Nov 2021
AOSL, FLGT, AMRC, and SAIA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 19, 2021.

New Strong Buy Stocks for November 19th

10:45am, Friday, 19'th Nov 2021
AOSL, FLGT, LAZY, MATX, and SCHN have been added to the Zacks Rank #1 (Strong Buy) List on November 19, 2021.
The genetic testing company delivered a solid performance in Q3.
Related Stocks: VIPS , RPM , CRSR , BATRA , ZUMZ , SHC , CHE , FLGT , MKSI , NSP , EXR , SCHW , EME , BK , WAL ,

Fulgent Genetics (NASDAQ:FLGT) Updates FY 2021 Earnings Guidance

06:20pm, Wednesday, 17'th Nov 2021 Dakota Financial News
Fulgent Genetics (NASDAQ:FLGT) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $16.000-$16.000 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.240. The company issued revenue guidance of $930 million-$930 million, compared to the consensus revenue estimate of []
Good things could be on the horizon when a stock surpasses the 200-day simple moving average. How should investors react?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE